| Literature DB >> 33308235 |
Michael J Wheeler1,2,3, Daniel J Green4, Ester Cerin5,6,7, Kathryn A Ellis8, Ilkka Heinonen4,9,10, Jaye Lewis4, Louise H Naylor4, Neale Cohen5, Robyn Larsen5, Paddy C Dempsey5,11,12, Bronwyn A Kingwell5, Neville Owen5,13, David W Dunstan4,5,6.
Abstract
BACKGROUND: Postprandial glucose, insulin, and triglyceride metabolism is impaired by prolonged sitting, but enhanced by exercise. The aim of this study was to assess the effects of a continuous exercise bout with and without intermittent active interruptions to prolonged sitting on postprandial glucose, insulin, and triglycerides.Entities:
Keywords: Exercise; Glucose; Insulin resistance; Lipids; Postprandial; Sedentary behavior
Mesh:
Substances:
Year: 2020 PMID: 33308235 PMCID: PMC7734727 DOI: 10.1186/s12966-020-01057-9
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Fig. 1Consolidated Standards of Reporting Trials flow diagram
Fig. 2Experimental design. Participants completed three conditions in a random order separated by a minimum of six days: sitting (SIT): uninterrupted sitting (8-h, control); exercise+sitting (EX+SIT): sitting (1-h), moderate-intensity walking (30-min, denoted by walking figure) followed by uninterrupted sitting (6.5-h); exercise+breaks (EX+BR): sitting (1-h), moderate-intensity walking (30-min) followed by sitting (6.5-h) interrupted every 30-min with 3-min of light-intensity walking. Walking breaks are denoted by dashed lines in the EX+BR condition
Participant characteristics
| Characteristic | ( |
|---|---|
| Sex (female/male) | 35 / 32 |
| Age (years) | 67 ± 7 |
| Body mass index (kg/m2) | 31.2 ± 4.1 |
| Waist circumference (cm) | 105.4 ± 11.9 |
| Impaired fasting glucose a | 11 (16%) |
| Fasting glucose (mmol/L) b | 5.2 ± 0.5 |
| Fasting insulin (pmol/L) b | 51.6 [41.4–74.9] |
| HOMA2%β b | 105 ± 31 |
| HOMA2-IR b | 1.3 ± 0.6 |
| Hypertension c | 25 (37%) |
| Systolic blood pressure (mm Hg) b | 125 ± 14 |
| Diastolic blood pressure (mm Hg) b | 74 ± 10 |
| Resting heart rate (bpm) b | 62 ± 1 |
| Fasting triglycerides (mmol/L) b | 1.2 [0.9–1.6] |
| Fasting total cholesterol (mmol/L) b | 5.2 ± 1.0 |
| Fasting HDL-cholesterol (mmol/L) b | 1.3 ± 0.3 |
| Fasting LDL-cholesterol (mmol/L) b | 3.3 ± 0.8 |
Data expressed as mean ± SD or n (%), fasting insulin and triglycerides are expressed as median [interquartile range]. a Impaired fasting glucose defined as 5.6 mmol/L to 6.9 mmol/L according to current guidelines [25]. b Average of 3 fasting measures across each condition. c hypertension defined as ≥130 mmHg systolic or ≥ 80 mmHg diastolic according to current guidelines [22]
Fig. 3Postprandial glucose, insulin, insulin:glucose ratio and triglycerides. Panels a-d represent glucose, insulin, insulin:glucose ratio and triglycerides, respectively, displayed as a time course over 8-h. The shaded area represents the timing of the moderate-intensity exercise bout performed in exercise+sitting (EX+SIT) and exercise+breaks (EX+BR). Panels e-h represent glucose, insulin, insulin:glucose ratio and triglycerides, respectively, displayed as the total area under the curve (tAUC). For EX+SIT and EX+BR, the percentage change relative to sitting (SIT) is displayed within the bar. Data are marginal means and SEM, adjusted for age, sex, waist circumference, baseline values, change in plasma volume, testing site and treatment order. * P < 0.05 SIT vs EX+BR; # P < 0.05 SIT vs EX+SIT
Fig. 4Meal-specific incremental area under the curve. Panels a-d represent the meal-specific insulin, glucose, insulin:glucose ratio, and triglyceride response, respectively, displayed as the positive incremental area under the curve (iAUC). The breakfast response represents the increase above the pre-breakfast time point until the pre-lunch time point. The lunch response represents the increase above the pre-lunch time point until the final time point. For EX+SIT and EX+BR, the change relative to sitting (SIT) is displayed within the bar. Data are marginal means and SEM, adjusted for age, sex, waist circumference, baseline values, change in plasma volume, testing site and treatment order
Fig. 5Associations between intervention-induced change and fasting baseline variables. Panels A-C represent the curvilinear relationships between intervention-induced change in insulin tAUC and HOMA2-IR, insulin tAUC and HOMA2-%β, triglyceride tAUC and fasting triglycerides, respectively. Fasting baseline variables were taken as the average across three conditions. The curved black line represents the line of best fit, calculated from a mixed model controlling for age, sex, waist circumference, change in plasma volume, testing site and treatment order. The shaded area represents the 95% confidence bands; ln indicates natural logarithm